{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:49:31Z","timestamp":1776120571493,"version":"3.50.1"},"reference-count":332,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010790","name":"Erasmus+","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001655","name":"Deutscher Akademischer Austauschdienst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.critrevonc.2026.105233","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T23:10:36Z","timestamp":1772320236000},"page":"105233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Maternally Expressed Gene 3 (MEG3) LncRNA: The silent guardian against solid and hematological malignancies"],"prefix":"10.1016","volume":"221","author":[{"given":"Noha M.","family":"Elemam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah H.","family":"Rashwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeina I.","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana Hassan","family":"Sweillam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia Wagih","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doha Ahmed","family":"Ghonim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Seada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Joseph","family":"Kiriacos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia M.","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem A.","family":"Assal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6268-7942","authenticated-orcid":false,"given":"Rana A.","family":"Youness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10911-022-09511-z","article-title":"Decoding insulin-like growth factor signaling pathway from a non-coding rnas perspective: a step towards precision oncology in breast cancer","volume":"27","author":"ZeinElAbdeen","year":"2022","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ncrna.2021.11.001","article-title":"What is beyond LncRNAs in breast cancer: a special focus on colon cancer-associated Transcript-1 (CCAT-1)","volume":"6","author":"Selem","year":"2021","journal-title":"Noncoding RNA Res."},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105233_bib3","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.3390\/cancers14215244","article-title":"Molecular engines, therapeutic targets, and challenges in pediatric brain tumors: a special emphasis on hydrogen sulfide and RNA-based nano-delivery","volume":"14","author":"Fahmy","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/BD-200454","article-title":"miR-744\/eNOS\/NO axis: a novel target to halt triple negative breast cancer progression","volume":"40","author":"El Kilany","year":"2021","journal-title":"Breast Dis."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105233_bib5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.bbagrm.2014.08.012","article-title":"LncRNA: a link between RNA and cancer","volume":"1839","author":"Yang","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA) Gene Regulatory Mechanisms"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ncrna.2019.01.003","article-title":"Long non-coding RNAs: functional regulatory players in breast cancer","volume":"4","author":"Youness","year":"2019","journal-title":"Noncoding RNA Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/2211536609666201209152949","article-title":"miRNA-506-3p directly regulates rs10754339 (A\/G) in the immune checkpoint protein B7-H4 in breast cancer","volume":"9","author":"El Din","year":"2020","journal-title":"Microrna"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2217\/pme-2022-0005","article-title":"miR-516a-3P, a potential circulating biomarker in hepatocellular carcinoma, correlated with rs738409 polymorphism in PNPLA3","volume":"19","author":"Youssef","year":"2022","journal-title":"Per Med"},{"key":"10.1016\/j.critrevonc.2026.105233_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1519103","article-title":"Deciphering the mysteries of MEG3 LncRNA and its implications in genitourinary cancers","volume":"15","author":"Assal","year":"2025","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102329","article-title":"MIAT: a pivotal oncogenic long noncoding RNA tunning the hallmarks of solid malignancies","volume":"54","author":"Rostom","year":"2025","journal-title":"Transl. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105233_bib11","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/jcp.31076","article-title":"Decoding hepatocarcinogenesis from a noncoding RNAs perspective","volume":"238","author":"El-Aziz","year":"2023","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104312","article-title":"Involvement of CircRNAs in regulating the \"new generation of cancer hallmarks\": a special depiction on hepatocellular carcinoma","volume":"196","author":"Dawoud","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101961","article-title":"A novel epigenetic strategy to concurrently block immune checkpoints PD-1\/PD-L1 and CD155\/TIGIT in hepatocellular carcinoma","volume":"45","author":"Assal","year":"2024","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib14","article-title":"Role of hydrogen sulfide in oncological and non-oncological disorders and its regulation by non-coding RNAs: a comprehensive review","volume":"10","author":"Youness","year":"2024","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.critrevonc.2026.105233_bib15","article-title":"Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19\/iNOS\/PD-L1 axis","volume":"44","author":"Soliman","year":"2023","journal-title":"Photo Photodyn. Ther."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105233_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cells13151245","article-title":"A comprehensive insight and in silico analysis of circrnas in hepatocellular carcinoma: a step toward ncRNA-based precision medicine","volume":"13","author":"Youness","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105233_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101730","article-title":"Unlocking the potential of non-coding RNAs in cancer research and therapy","volume":"35","author":"Uppaluri","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib18","article-title":"Direct and indirect modulation of STAT3\/CSE\/H(2)S axis in triple negative breast cancer by non-coding RNAs: MALAT-1 lncRNA, miR-486-5p and miR-30a-5p","volume":"265","author":"Youness","year":"2025","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.critrevonc.2026.105233_bib19","article-title":"miR-17-5p\/STAT3\/H19: a novel regulatory axis tuning ULBP2 expression in young breast cancer patients","volume":"263","author":"Abdelhamid","year":"2024","journal-title":"Pathol. Res Pr."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib20","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1038\/s41598-024-55083-9","article-title":"The lncRNAs Gas5, MALAT1 and SNHG8 as diagnostic biomarkers for epithelial malignant pleural mesothelioma in Egyptian patients","volume":"14","author":"Elkahwagy","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s11010-022-04378-4","article-title":"MALAT-1\/p53\/miR-155\/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer","volume":"477","author":"Abdel-Latif","year":"2022","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.critrevonc.2026.105233_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102365","article-title":"In-vitro immune-modulation of triple-negative breast cancer through targeting miR-30a-5p\/MALAT1 axis using nano-PDT combinational approach","volume":"55","author":"Ramzy","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib23","article-title":"Long non-coding RNA MEG3 in metal carcinogenesis","volume":"11","author":"Zhang","year":"2023","journal-title":"Toxics"},{"key":"10.1016\/j.critrevonc.2026.105233_bib24","article-title":"Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies","volume":"256","author":"Rashwan","year":"2024","journal-title":"Pathol. Res Pr."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/en.2009-0657","article-title":"Maternally expressed Gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions","volume":"151","author":"Zhang","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.critrevonc.2026.105233_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154850","article-title":"The complex role of MEG3: an emerging long non-coding RNA in breast cancer","volume":"251","author":"Hussain","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib27","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/JME-12-0008","article-title":"MEG3 noncoding RNA: a tumor suppressor","volume":"48","author":"Zhou","year":"2012","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246032","article-title":"The biological roles and molecular mechanisms of long non-coding RNA MEG3 in the hallmarks of cancer","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105233_bib29","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1210\/jc.2003-030222","article-title":"A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells","volume":"88","author":"Zhang","year":"2003","journal-title":"J. Clin. Endocrinol. & Metab."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib30","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1002\/jcb.27604","article-title":"Interaction of long noncoding RNA MEG3 with miRNAs: a reciprocal regulation","volume":"120","author":"Moradi","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105233_bib31","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.3390\/cancers14246032","article-title":"The biological roles and molecular mechanisms of long non-coding RNA MEG3 in the hallmarks of cancer","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105233_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.humgen.2025.201470","article-title":"Altered expression patterns of lncRNA MEG3 and LINC01611 in patients with colorectal cancer","volume":"46","author":"Faraji","year":"2025","journal-title":"Hum. Gene"},{"key":"10.1016\/j.critrevonc.2026.105233_bib33","article-title":"LncRNA MEG3: potential stock for precision treatment of cardiovascular diseases","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.critrevonc.2026.105233_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115937","article-title":"Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS\/MS and its application in the clinical determination in patients with tumors associated with overactive bladder","volume":"240","author":"Lou","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105233_bib35","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.7150\/ijbs.58910","article-title":"Long non-coding RNA MEG3 promotes cisplatin-induced nephrotoxicity through regulating AKT\/TSC\/mTOR-mediated autophagy","volume":"17","author":"Jing","year":"2021","journal-title":"Int J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/jpm11060513","article-title":"Role of long non-coding RNA polymorphisms in cancer chemotherapeutic response","volume":"11","author":"Zhang","year":"2021","journal-title":"J. Pers. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41419-018-0305-7","article-title":"Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting \u03b2-catenin by activating PKM2 and inactivating PTEN","volume":"9","author":"Zheng","year":"2018","journal-title":"Cell Death & Dis."},{"key":"10.1016\/j.critrevonc.2026.105233_bib38","doi-asserted-by":"crossref","first-page":"16611","DOI":"10.2147\/JIR.S536310","article-title":"The YTHDC1-m6A-MEG3 regulatory axis in radiation-induced liver injury: deciphering early-stage epitranscriptomic alterations and molecular dynamics","volume":"18","author":"Guo","year":"2025","journal-title":"J. Inflamm. Res"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105233_bib39","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/pharmaceutics16121582","article-title":"Precisely tailoring molecular structure of doxorubicin prodrugs to enable stable nanoassembly, rapid activation, and potent antitumor effect","volume":"16","author":"Feng","year":"2024","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061480","article-title":"The Fra-1\/AP-1 oncoprotein: from the \"undruggable\" transcription factor to therapeutic targeting","volume":"14","author":"Casalino","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0955-0674(97)80068-3","article-title":"AP-1 function and regulation","volume":"9","author":"Karin","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105233_bib42","article-title":"Erwin F Wagner.","volume":"20","year":"2001","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105233_bib43","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1128\/MCB.23.19.7030-7043.2003","article-title":"Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor","volume":"23","author":"Monje","year":"2003","journal-title":"Mol. Cell Biol."},{"issue":"6345","key":"10.1016\/j.critrevonc.2026.105233_bib44","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/353670a0","article-title":"Phosphorylation of c-jun mediated by MAP kinases","volume":"353","author":"Pulverer","year":"1991","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib45","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/MCB.19.6.4289","article-title":"A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5","volume":"19","author":"Marinissen","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib46","article-title":"Regulation of Jun and Fos AP-1 transcription factors by JNK MAPKs signaling cascade in areca nut extract treated KB cells","volume":"27","author":"Nagesh","year":"2021","journal-title":"Biochem Biophys. Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib47","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1101\/gr.267898.120","article-title":"AP-1 subunits converge promiscuously at enhancers to potentiate transcription","volume":"31","author":"Seo","year":"2021","journal-title":"Genome Res"},{"key":"10.1016\/j.critrevonc.2026.105233_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117225","article-title":"A multi-omics approach to reveal critical mechanisms of activator protein 1 (AP-1)","volume":"178","author":"Li","year":"2024","journal-title":"Biomed. & Pharmacother."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105233_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102326","article-title":"The role of AP-1 transcription factors in plasma cell biology and multiple myeloma pathophysiology","volume":"13","author":"Fan","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib50","first-page":"29","article-title":"Critically dysregulated signaling pathways and clinical utility of the pathway biomarkers in lymphoid malignancies","volume":"4","author":"Sun","year":"2018","journal-title":"Chronic Dis. Transl. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12672-025-01783-1","article-title":"Advances in the relationship between AP-1 and tumorigenesis, development and therapy resistance","volume":"16","author":"Xue","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib52","article-title":"The complex role of MEG3: an emerging long non-coding RNA in breast cancer","volume":"251","author":"Hussain","year":"2023","journal-title":"Pathol. Res Pr."},{"issue":"27","key":"10.1016\/j.critrevonc.2026.105233_bib53","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1038\/onc.2017.14","article-title":"LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1alpha translation","volume":"36","author":"Zhou","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105233_bib54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev-pharmtox-011112-140338","article-title":"Turning off AKT: PHLPP as a drug target","volume":"54","author":"Newton","year":"2014","journal-title":"Annu Rev. Pharm. Toxicol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib55","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mc.23702","article-title":"RhoGDIbeta inhibition via miR-200c\/AUF1\/SOX2\/miR-137 axis contributed to lncRNA MEG3 downregulation-mediated malignant transformation of human bronchial epithelial cells","volume":"63","author":"Yang","year":"2024","journal-title":"Mol. Carcinog."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib56","first-page":"345","article-title":"Scutellarein treats neuroblastoma by regulating the expression of multiple targets","volume":"10","author":"Zhai","year":"2024","journal-title":"Ibrain"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","article-title":"Wnt\/beta-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy","volume":"24","author":"Wu","year":"2025","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib59","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.gastro.2011.12.001","article-title":"Dysregulation of Wnt\/beta-catenin signaling in gastrointestinal cancers","volume":"142","author":"White","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3892\/mco.2024.2743","article-title":"Wnt signaling and tumors (Review)","volume":"21","author":"Wang","year":"2024","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib62","article-title":"STAT3 activation: a key factor in tumor immunoescape","volume":"2","author":"Rebe","year":"2013","journal-title":"JAKSTAT"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib63","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jmedgenet-2020-107447","article-title":"DDX58(RIG-I)-related disease is associated with tissue-specific interferon pathway activation","volume":"59","author":"Prasov","year":"2022","journal-title":"J. Med Genet"},{"key":"10.1016\/j.critrevonc.2026.105233_bib64","article-title":"Epigenetic remodeling under oxidative stress: mechanisms driving tumor metastasis","volume":"3","author":"Peng","year":"2024","journal-title":"MedComm Oncol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib65","article-title":"Endocrine-disrupting chemicals (EDCs) and epigenetic regulation in embryonic development: mechanisms, impacts, and emerging trends","volume":"14","author":"Akanbi","year":"2025","journal-title":"Toxicol. Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3892\/etm.2020.9162","article-title":"Epigenetic modulation of the MAPK pathway prevents isoflurane-induced neuronal apoptosis and cognitive decline in aged rats","volume":"20","author":"Huang","year":"2020","journal-title":"Exp. Ther. Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib67","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1124\/mol.111.072314","article-title":"Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects","volume":"80","author":"Tung","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib68","doi-asserted-by":"crossref","unstructured":"Urvalek, A., K. Laursen, and L. Gudas, The Roles of Retinoic Acid and Retinoic Acid Receptors in Inducing Epigenetic Changes. 2014.","DOI":"10.1007\/978-94-017-9050-5_7"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib69","first-page":"381","article-title":"Brain and other central nervous system tumor statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA A Cancer Journal Clinicians"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105233_bib70","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/17425247.2019.1676227","article-title":"Novel therapeutics for brain tumors: current practice and future prospects","volume":"17","author":"El Demerdash","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.critrevonc.2026.105233_bib72","series-title":"IntechOpen: Rijeka","article-title":"Mechanisms of aggressiveness in glioblastoma: prognostic and potential therapeutic insights, in evolution of the molecular biology of brain tumors and the therapeutic implications","author":"C\u00e9line","year":"2013"},{"key":"10.1016\/j.critrevonc.2026.105233_bib73","article-title":"Prognostic value of MEG3 and its correlation with immune infiltrates in gliomas","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib74","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11060-018-2874-9","article-title":"Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma","volume":"140","author":"Zhao","year":"2018","journal-title":"J. NeuroOncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107398","article-title":"LC3A-mediated autophagy elicits PERK-eIF2\u03b1-ATF4 axis activation and mitochondrial dysfunction: exposing vulnerability in aggresome-positive cancer cells","volume":"300","author":"Amer","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2026.105233_bib76","article-title":"Research square","author":"Avsar","year":"2022","journal-title":"Silenci MEG3 gene Promot. antiCancer Act. Drug Sensit. glioma"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib77","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.3892\/mmr.2017.6897","article-title":"Long non\u2011coding RNA MEG3 contributes to cisplatin\u2011induced apoptosis via inhibition of autophagy in human glioma cells","volume":"16","author":"Ma","year":"2017","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.critrevonc.2026.105233_bib78","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clineuro.2017.05.002","article-title":"Genetic and epigenetic alterations in meningiomas","volume":"158","author":"Galani","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105233_bib79","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.celrep.2018.03.013","article-title":"Comprehensive molecular profiling identifies FOXM1 as a key transcription factor for meningioma proliferation","volume":"22","author":"Vasudevan","year":"2018","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib80","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","article-title":"Maternally expressed Gene 3, an imprinted noncoding RNA Gene, is associated with meningioma pathogenesis and progression","volume":"70","author":"Zhang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105233_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.537763","article-title":"Long non-coding RNA MEG3 modifies cell-cycle, migration, invasion, and proliferation through AKAP12 by sponging miR-29c in meningioma cells","volume":"10","author":"Ding","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib82","unstructured":"Cancer.Net. Head and Neck Cancer: Statistics. 2023 31 July 2023]; Available from: \u3008https:\/\/www.cancer.net\/cancer-types\/head-and-neck-cancer\/statistics#:\u223c:text=Head%20and%20neck%20cancer%20accounts,and%20neck%20cancer%20in%202020\u3009."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib83","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA a cancer journal clinicians"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib84","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib85","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and neck cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib86","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1200\/JOP.2017.026856","article-title":"Cancers of the major salivary gland","volume":"14","author":"Son","year":"2018","journal-title":"J. Oncol. Pr."},{"key":"10.1016\/j.critrevonc.2026.105233_bib87","unstructured":"Institute, N.C. Head and Neck Cancers. 2021 31 July 2023]; Available from: \u3008https:\/\/www.cancer.gov\/types\/head-and-neck\/head-neck-fact-sheet#r1\u3009."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105233_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193181","article-title":"MEG3 expression indicates lymph node metastasis and presence of cancer-associated fibroblasts in papillary thyroid cancer","volume":"11","author":"Dadafarin","year":"2022","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105233_bib89","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1002\/cam4.3002","article-title":"Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin","volume":"9","author":"Ji","year":"2020","journal-title":"Cancer Med"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105233_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12101696","article-title":"C10orf55, CASC2, and SFTA1P lncRNAs are potential biomarkers to assess radiation therapy response in head and neck cancers","volume":"12","author":"Paszkowska","year":"2022","journal-title":"J. Pers. Med"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105233_bib91","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/hed.25136","article-title":"Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma","volume":"40","author":"Haque","year":"2018","journal-title":"Head. Neck"},{"key":"10.1016\/j.critrevonc.2026.105233_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109340","article-title":"LncRNA MEG3 attenuates the malignancy of retinoblastoma cells through inactivating PI3K \/Akt\/mTOR signaling pathway","volume":"226","author":"Yan","year":"2023","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.critrevonc.2026.105233_bib93","unstructured":"American Cancer Society. Key statistics for retinoblastoma. 2020 9 August 2023]; Available from: \u3008https:\/\/www.cancer.org\/cancer\/types\/retinoblastoma\/about\/key-statistics.html\u3009."},{"issue":"101","key":"10.1016\/j.critrevonc.2026.105233_bib94","first-page":"1","article-title":"Retinoblastoma: a curable, rare and deadly blinding disease","volume":"31","author":"Bowman","year":"2018","journal-title":"Community Eye Health"},{"issue":"9824","key":"10.1016\/j.critrevonc.2026.105233_bib95","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","article-title":"Retinoblastoma","volume":"379","author":"Dimaras","year":"2012","journal-title":"Lancet"},{"issue":"7381","key":"10.1016\/j.critrevonc.2026.105233_bib96","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/481269a","article-title":"The path to retinoblastoma","volume":"481","author":"Sage","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib97","doi-asserted-by":"crossref","DOI":"10.4103\/jcrt.JCRT_718_18","article-title":"Aggressive-fungating retinal hemangioblastoma","volume":"17","author":"Menon","year":"2021","journal-title":"J. Cancer Res. Ther."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105233_bib98","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.ajpath.2018.06.013","article-title":"Distinct gene expression profiles define anaplastic grade in retinoblastoma","volume":"188","author":"Hudson","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib99","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12967-017-1372-8","article-title":"Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma","volume":"15","author":"Gao","year":"2017","journal-title":"J. Transl. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib100","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s13277-015-4564-y","article-title":"Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt\/\u03b2-catenin pathway","volume":"37","author":"Gao","year":"2016","journal-title":"Tumor Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib101","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12967-017-1372-8","article-title":"Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma","volume":"15","author":"Gao","year":"2017","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105233_bib102","first-page":"3111","article-title":"LncRNA MEG3 inhibits retinoblastoma invasion and metastasis by inducing \u03b2-catenin degradation","volume":"12","author":"Gao","year":"2022","journal-title":"Am. J. Cancer Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13813","article-title":"Identification of non-coding RNAs and their functional network associated with optic nerve invasion in retinoblastoma","volume":"9","author":"Sun","year":"2023","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib104","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mc.22569","article-title":"Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma","volume":"56","author":"Chak","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.critrevonc.2026.105233_bib105","unstructured":"Soceity, A.C. Key Statistics for Oral Cavity and Oropharyngeal Cancers. 2023 31 July 2023]; Available from: \u3008https:\/\/www.cancer.org\/cancer\/types\/oral-cavity-and-oropharyngeal-cancer\/about\/key-statistics.html\u3009."},{"key":"10.1016\/j.critrevonc.2026.105233_bib106","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1172-1-23","article-title":"Nasopharyngeal carcinoma","volume":"1","author":"Brennan","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.critrevonc.2026.105233_bib107","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.oraloncology.2017.07.020","article-title":"Familial aggregation of nasopharyngeal carcinoma in Taiwan","volume":"73","author":"Huang","year":"2017","journal-title":"Oral. Oncol."},{"issue":"29","key":"10.1016\/j.critrevonc.2026.105233_bib108","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1200\/JCO.2015.60.7846","article-title":"Nasopharyngeal cancer: molecular landscape","volume":"33","author":"Bruce","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib109","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40880-016-0103-5","article-title":"A new prognostic histopathologic classification of nasopharyngeal carcinoma","volume":"35","author":"Wang","year":"2016","journal-title":"Chin. J. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib110","first-page":"1355","article-title":"Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia","volume":"146","author":"Pathmanathan","year":"1995","journal-title":"Am. J. Pathol."},{"issue":"29","key":"10.1016\/j.critrevonc.2026.105233_bib111","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1200\/JCO.2015.60.9347","article-title":"Management of nasopharyngeal carcinoma: current practice and future perspective","volume":"33","author":"Lee","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"10022","key":"10.1016\/j.critrevonc.2026.105233_bib112","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib113","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities","volume":"110","author":"Sun","year":"2014","journal-title":"Radio. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib114","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.radonc.2012.08.022","article-title":"Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy","volume":"104","author":"Zhang","year":"2012","journal-title":"Radio. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1535-6108(04)00119-9","article-title":"Focus on nasopharyngeal carcinoma","volume":"5","author":"Lo","year":"2004","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib116","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semcancer.2011.12.011","article-title":"Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches","volume":"22","author":"Lo","year":"2012","journal-title":"Semin Cancer Biol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105233_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012745","article-title":"Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib118","doi-asserted-by":"crossref","first-page":"958","DOI":"10.21037\/tcr.2019.12.41","article-title":"LncRNA MEG3 inhibits the development of nasopharyngeal carcinoma by sponging miR-543 targeting KLF4","volume":"9","author":"Ning","year":"2020","journal-title":"Transl. Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib119","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12943-017-0620-0","article-title":"MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hed.26917","article-title":"Lnc-MEG3 inhibits invasion, migration, and epithelial- mesenchymal transition of nasopharyngeal carcinoma cells by regulating sequestosome 1","volume":"44","author":"Zhou","year":"2022","journal-title":"Head. Neck"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib121","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/jcmm.15759","article-title":"Long non-coding RNA MEG3 promotes autophagy and apoptosis of nasopharyngeal carcinoma cells via PTEN up-regulation by binding to microRNA-21","volume":"25","author":"Lin","year":"2021","journal-title":"J. Cell Mol. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib122","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/carcin\/bgv007","article-title":"Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment","volume":"36","author":"Guo","year":"2015","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105233_bib123","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1158\/0008-5472.CAN-09-4099","article-title":"Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics","volume":"70","author":"Feng","year":"2010","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib124","doi-asserted-by":"crossref","first-page":"8320","DOI":"10.1038\/s41598-017-08890-2","article-title":"Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/j.1460-2075.1993.tb05678.x","article-title":"mdm2 expression is induced by wild type p53 activity","volume":"12","author":"Barak","year":"1993","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib126","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ncb1875","article-title":"p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug","volume":"11","author":"Wang","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib127","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105233_bib128","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9977131","article-title":"Nanoparticles for oral cancer diagnosis and therapy","volume":"2021","author":"Zheng","year":"2021","journal-title":"Bioinorg. Chem. Appl."},{"key":"10.1016\/j.critrevonc.2026.105233_bib129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/bs.acc.2018.05.002","article-title":"Role of salivary biomarkers in oral cancer detection","volume":"86","author":"Khurshid","year":"2018","journal-title":"Adv. Clin. Chem."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/0022034518759068","article-title":"Targeting the DNA damage response in OSCC with TP53 mutations","volume":"97","author":"Lindemann","year":"2018","journal-title":"J. Dent. Res"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105233_bib131","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/cac2.12194","article-title":"The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential","volume":"41","author":"Meng","year":"2021","journal-title":"Cancer Commun (Lond)"},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105233_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13235944","article-title":"Long non-coding RNA (lncRNA) in oral squamous cell carcinoma: biological function and clinical application","volume":"13","author":"Tang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib133","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/2231-0762.186805","article-title":"Distant metastasis from oral cancer: a review and molecular biologic aspects","volume":"6","author":"Irani","year":"2016","journal-title":"J. Int Soc. Prev. Community Dent."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105233_bib134","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.3390\/ijms11093106","article-title":"Identification of tetranectin as a potential biomarker for metastatic oral cancer","volume":"11","author":"Arellano-Garcia","year":"2010","journal-title":"Int J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105233_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136795","article-title":"Salivary cytokines as biomarkers for oral squamous cell carcinoma: a systematic review","volume":"22","author":"Ferrari","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib136","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/jcmm.14376","article-title":"Metabolic changes during malignant transformation in primary cells of oral lichen planus: succinate accumulation and tumour suppression","volume":"24","author":"Yang","year":"2020","journal-title":"J. Cell Mol. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib137","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/2211-5463.13532","article-title":"Long noncoding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3","volume":"13","author":"Hu","year":"2023","journal-title":"FEBS Open Bio"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib138","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3892\/ol.2021.13045","article-title":"Maternally expressed 3 inhibits the biological activity of oral squamous cell carcinoma SCC25 and CAL27 cell lines","volume":"22","author":"Wang","year":"2021","journal-title":"Oncol. Lett."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105233_bib139","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1158\/0008-5472.CAN-14-0978","article-title":"Downregulated miR329 and miR410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b","volume":"74","author":"Shiah","year":"2014","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105233_bib140","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/iub.2012","article-title":"LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma","volume":"71","author":"Tan","year":"2019","journal-title":"IUBMB Life"},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105233_bib141","first-page":"8315","article-title":"Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21","volume":"22","author":"Zhang","year":"2018","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib142","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.3892\/ol.2017.6682","article-title":"Long non-coding RNA MEG3 inhibits the proliferation and metastasis of oral squamous cell carcinoma by regulating the WNT\/beta-catenin signaling pathway","volume":"14","author":"Liu","year":"2017","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib143","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/odi.13103","article-title":"Association of long non-coding RNA MEG3 polymorphisms with oral squamous cell carcinoma risk","volume":"25","author":"Hou","year":"2019","journal-title":"Oral. Dis."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib144","first-page":"5","article-title":"Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior","volume":"48","author":"Jia","year":"2016","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105233_bib145","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/ijc.28667","article-title":"Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma","volume":"135","author":"Jia","year":"2014","journal-title":"Int J. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105233_bib146","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/odi.13245","article-title":"Up-regulation of plasma lncRNA CACS15 distinguished early-stage oral squamous cell carcinoma patient","volume":"26","author":"Zhang","year":"2020","journal-title":"Oral. Dis."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib147","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jfma.2020.09.006","article-title":"LncRNA MEG3 inhibits self-renewal and invasion abilities of oral cancer stem cells by sponging miR-421","volume":"120","author":"Chen","year":"2021","journal-title":"J. Formos. Med Assoc."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib148","article-title":"Epidemiology and risk factors of melanoma: a review","volume":"11","author":"Conforti","year":"2021","journal-title":"Dermatol. Pract. & Concept."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib149","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/pcmr.12172","article-title":"Why is melanoma so metastatic?","volume":"27","author":"Braeuer","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105233_bib150","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1002\/jcb.27061","article-title":"LncRNA MEG3 repressed malignant melanoma progression via inactivating Wnt signaling pathway","volume":"119","author":"Li","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105233_bib151","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2086564","article-title":"lncRNA-MEG3 suppresses the proliferation and invasion of melanoma by regulating CYLD expression mediated by sponging miR-499-5p","volume":"2018","author":"Long","year":"2018","journal-title":"BioMed. Res. Int."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib152","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12935-019-1087-4","article-title":"LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21\/E-cadherin axis","volume":"20","author":"Wu","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib153","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12672-021-00414-9","article-title":"LncRNA POU3F3 promotes melanoma cell proliferation by downregulating lncRNA MEG3","volume":"12","author":"Liu","year":"2021","journal-title":"Discov. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib154","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11010-022-04515-z","article-title":"Upregulation LncRNA MEG3 expression suppresses proliferation and metastasis in melanoma via miR-208\/SOX4","volume":"478","author":"Yang","year":"2023","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib155","first-page":"321","article-title":"Molecular basis and clinical features of neuroblastoma","volume":"4","author":"Takita","year":"2021","journal-title":"JMA J."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105233_bib156","article-title":"Neuroblastoma: a case of massive hepatomegaly","volume":"13","author":"Ali","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.critrevonc.2026.105233_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00009","article-title":"Neuroblastoma\u2014a neural crest derived embryonal malignancy","volume":"12","author":"Johnsen","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.critrevonc.2026.105233_bib158","doi-asserted-by":"crossref","first-page":"j1863","DOI":"10.1136\/bmj.j1863","article-title":"Neuroblastoma","volume":"357","author":"Shohet","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2026.105233_bib159","unstructured":"American Cancer Society. Key statistics about neuroblastoma. 2021 10 August 2023a]; Available from: \u3008https:\/\/www.cancer.org\/cancer\/types\/neuroblastoma\/about\/key-statistics.html\u3009."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib160","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/cancers13040736","article-title":"Neuroblastoma invasion strategies are regulated by the extracellular matrix","volume":"13","author":"Gavin","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib161","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/01913123.2016.1187689","article-title":"Aggressive human neuroblastomas show a massive increase in the numbers of autophagic vacuoles and damaged mitochondria","volume":"40","author":"Samardzija","year":"2016","journal-title":"Ultrastruct. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib162","first-page":"1","article-title":"Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha\/p50alpha protein levels compared to low stage neuroblastomas","volume":"8","author":"Fransson","year":"2013","journal-title":"J. Mol. Signal."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib163","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/21678707.2017.1304212","article-title":"Emerging and investigational therapies for neuroblastoma","volume":"5","author":"Applebaum","year":"2017","journal-title":"Expert Opin. Orphan Drugs"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105233_bib164","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.bjc.6602478","article-title":"Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour","volume":"92","author":"Astuti","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib165","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ijc.26052","article-title":"MEG3 imprinted gene contribution in tumorigenesis","volume":"129","author":"Benetatos","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib166","doi-asserted-by":"crossref","first-page":"36268","DOI":"10.1038\/srep36268","article-title":"MEG3, HCN3 and linc01105 influence the proliferation and apoptosis of neuroblastoma cells via the HIF-1\u03b1 and p53 pathways","volume":"6","author":"Tang","year":"2016","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105233_bib167","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.7150\/ijbs.48126","article-title":"Downregulation of MEG3 promotes neuroblastoma development through FOXO1-mediated autophagy and mTOR-mediated epithelial-mesenchymal transition","volume":"16","author":"Ye","year":"2020","journal-title":"Int J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib168","article-title":"Upregulation of MEG3 inhibits neuroblastoma progression via decreasing proliferation and promoting apoptosis","volume":"5","author":"Ye","year":"2022","journal-title":"Life Res. J."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib169","doi-asserted-by":"crossref","first-page":"481","DOI":"10.18632\/aging.101406","article-title":"Associations between lncRNA MEG3 polymorphisms and neuroblastoma risk in Chinese children","volume":"10","author":"Zhuo","year":"2018","journal-title":"Aging (Albany NY)"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105233_bib170","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/jcmm.17258","article-title":"Downregulation of MEG3 and upregulation of EZH2 cooperatively promote neuroblastoma progression","volume":"26","author":"Ye","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105233_bib171","unstructured":"American Cancer Society. Key statistics for osteosarcoma. 2020 10 August 2023a]; Available from: \u3008https:\/\/www.cancer.org\/cancer\/types\/osteosarcoma\/about\/key-statistics.html\u3009."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105233_bib172","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.21873\/anticanres.13763","article-title":"Osteosarcoma of the upper extremities: a national analysis of the US population","volume":"39","author":"Maria","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.critrevonc.2026.105233_bib173","unstructured":"Rosen, G., et al., Bone tumors, in Holland-Frei Cancer Medicine. 5th edition. 2000, BC Decker."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105233_bib174","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2174\/1871530320666200821155756","article-title":"Vitamin D represses the aggressive potential of osteosarcoma","volume":"21","author":"Tahbazlahafi","year":"2021","journal-title":"Endocr. Metab. & Immune Disord. Drug Targets"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib175","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3892\/ol.2021.12909","article-title":"Upregulation of CENPF is linked to aggressive features of osteosarcoma","volume":"22","author":"Zou","year":"2021","journal-title":"Oncol. Lett."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105233_bib176","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41422-020-0370-1","article-title":"Wnt signaling and Loxl2 promote aggressive osteosarcoma","volume":"30","author":"Matsuoka","year":"2020","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib177","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbrc.2013.02.083","article-title":"Microarray expression profile of long noncoding RNAs in human osteosarcoma","volume":"433","author":"Li","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105233_bib178","first-page":"15138","article-title":"Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma","volume":"8","author":"Tian","year":"2015","journal-title":"Int J. Clin. Exp. Pathol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105233_bib179","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1172\/JCI72124","article-title":"Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis","volume":"124","author":"Marques Howarth","year":"2014","journal-title":"J. Clin. Invest"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105233_bib180","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1089\/dna.2016.3467","article-title":"Long noncoding RNA EWSAT1 promotes osteosarcoma cell growth and metastasis through suppression of MEG3 expression","volume":"35","author":"Sun","year":"2016","journal-title":"DNA Cell Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib181","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbrc.2017.06.174","article-title":"Inhibition of miR-664a interferes with the migration of osteosarcoma cells via modulation of MEG3","volume":"490","author":"Sahin","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105233_bib182","first-page":"632","article-title":"MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma","volume":"118","author":"Zhang","year":"2017","journal-title":"Bratisl. Lek. Listy"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib183","first-page":"1917","article-title":"MEG3 inhibits proliferation and invasion and promotes apoptosis of human osteosarcoma cells","volume":"15","author":"Shi","year":"2018","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105233_bib184","doi-asserted-by":"crossref","first-page":"13464","DOI":"10.1002\/jcp.28026","article-title":"LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1","volume":"234","author":"Shen","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib185","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.3390\/cimb45030146","article-title":"NOTCH signaling in osteosarcoma","volume":"45","author":"Zhang","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib186","first-page":"581","article-title":"LncRNA MEG3 inhibits proliferation and promotes apoptosis of osteosarcoma cells through regulating Notch signaling pathway","volume":"24","author":"Chen","year":"2020","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105233_bib187","first-page":"1901","article-title":"MEG3 targets miR-184 and Wnt\/\u03b2-catenin and modulates properties of osteosarcoma","volume":"25","author":"Li","year":"2020","journal-title":"FBL"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib188","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.gendis.2021.11.004","article-title":"LncRNA MEG3 promotes chemosensitivity of osteosarcoma by regulating antitumor immunity via miR-21-5p\/p53 pathway and autophagy","volume":"10","author":"Huang","year":"2023","journal-title":"Genes & Dis."},{"key":"10.1016\/j.critrevonc.2026.105233_bib189","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2022.01.026","article-title":"Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy","volume":"343","author":"Huang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.critrevonc.2026.105233_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on fundamental mechanisms of thyroid cancer","volume":"11","author":"Prete","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105233_bib191","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.critrevonc.2026.105233_bib192","unstructured":"The American Cancer Society. Key statistics for thyroid cancer. 2023 9 August 2023]; Available from: \u3008https:\/\/www.cancer.org\/cancer\/types\/thyroid-cancer\/about\/key-statistics.html\u3009."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105233_bib193","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.3390\/cells11193181","article-title":"MEG3 expression indicates lymph node metastasis and presence of cancer-associated fibroblasts in papillary thyroid cancer","volume":"11","author":"Dadafarin","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105233_bib194","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/790834","article-title":"Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer","volume":"2014","author":"Ragazzi","year":"2014","journal-title":"Int. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib195","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoto.2014.1","article-title":"Current thyroid cancer trends in the United States","volume":"140","author":"Davies","year":"2014","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105233_bib196","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM199302253280807","article-title":"Management of a solitary thyroid nodule","volume":"328","author":"Mazzaferri","year":"1993","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib197","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","article-title":"Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer","volume":"97","author":"Mazzaferri","year":"1994","journal-title":"Am. J. Med"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105233_bib198","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/000313480507100907","article-title":"The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer","volume":"71","author":"Podnos","year":"2005","journal-title":"Am. Surg."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105233_bib199","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00268-008-9588-7","article-title":"Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer","volume":"32","author":"Ahn","year":"2008","journal-title":"World J. Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2265.2006.02612.x","article-title":"Integrated 18F-FDG PET\/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT","volume":"65","author":"Jeong","year":"2006","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib201","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4149\/neo_2015_065","article-title":"Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1","volume":"62","author":"Wang","year":"2015","journal-title":"Neoplasma"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113023","article-title":"A four-enhancer RNA-based prognostic signature for thyroid cancer","volume":"412","author":"Liang","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.critrevonc.2026.105233_bib203","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.biopha.2018.06.087","article-title":"LncRNA MEG3 enhances 131I sensitivity in thyroid carcinoma via sponging miR-182","volume":"105","author":"Liu","year":"2018","journal-title":"Biomed. & Pharmacother."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105233_bib204","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41417-021-00318-4","article-title":"Cancer-associated fibroblasts: overview, progress, challenges, and directions","volume":"28","author":"Ping","year":"2021","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib205","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/35094091","article-title":"Tobacco and the global lung cancer epidemic","volume":"1","author":"Proctor","year":"2001","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib206","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer Journal Clinicians"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib207","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5144\/0256-4947.2005.1","article-title":"Lung cancer","volume":"25","author":"Maghfoor","year":"2005","journal-title":"Ann. Saudi Med"},{"key":"10.1016\/j.critrevonc.2026.105233_bib209","unstructured":"Simon, S., American Cancer Society. Lung cancer risks for non-smokers URL: https:\/\/www. cancer. org\/latest-news\/why-lung-cancer-strikes-nonsmokers. html [accessed 2020-02-28], 2020."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105233_bib211","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib212","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3390\/curroncol29030150","article-title":"Non-small-cell lung cancer in 2022: a review for general practitioners in oncology","volume":"29","author":"Mithoowani","year":"2022","journal-title":"Curr. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105233_bib213","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/thorax.57.11.992","article-title":"Lung cancer. Introduction","volume":"57","author":"Sethi","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.critrevonc.2026.105233_bib214","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-3-319-40389-2_14","article-title":"Small cell lung cancer","volume":"170","author":"Bernhardt","year":"2016","journal-title":"Cancer Treat. Res"},{"issue":"Pt 2","key":"10.1016\/j.critrevonc.2026.105233_bib215","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.semcancer.2022.04.001","article-title":"Small cell lung cancer: subtypes and therapeutic implications","volume":"86","author":"Wang","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib216","doi-asserted-by":"crossref","first-page":"v220","DOI":"10.1093\/annonc\/mdq191","article-title":"Neuroendocrine bronchial and thymic tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Oberg","year":"2010","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105233_bib217","doi-asserted-by":"crossref","first-page":"16143","DOI":"10.1002\/jcb.28895","article-title":"Long noncoding RNA MEG3 plays a promoting role in the proliferation, invasion, and angiogenesis of lung adenocarcinoma cells through the AKT pathway","volume":"120","author":"Li","year":"2019","journal-title":"J. Cell Biochem"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib218","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1074\/jbc.M116.750950","article-title":"MEG3 long noncoding RNA contributes to the epigenetic regulation of epithelial-mesenchymal transition in lung cancer cell lines","volume":"292","author":"Terashima","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105233_bib219","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1016\/S1470-2045(16)30123-1","article-title":"Novel therapeutic targets on the horizon for lung cancer","volume":"17","author":"Tan","year":"2016","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib220","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010104","article-title":"Transfer of extracellular vesicle-associated-RNAs induces drug resistance in ALK-translocated lung adenocarcinoma","volume":"11","author":"Kwok","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib221","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12022-020-09626-1","article-title":"Long non-coding rnas in pulmonary neuroendocrine neoplasms","volume":"31","author":"Narayanan","year":"2020","journal-title":"Endocr. Pathol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib222","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3349\/ymj.2022.63.3.229","article-title":"MEG3 LncRNA from exosomes released from cancer-associated fibroblasts enhances cisplatin chemoresistance in SCLC via a MiR-15a-5p\/CCNE1 axis","volume":"63","author":"Sun","year":"2022","journal-title":"Yonsei Med J."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105233_bib223","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2174\/1871520620666200721130700","article-title":"lncRNAs as potential targets in small cell lung cancer: MYC -dependent regulation","volume":"20","author":"Tokgun","year":"2020","journal-title":"Anticancer Agents Med Chem."},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105233_bib224","first-page":"5938","article-title":"High expression of lncRNA MEG3 participates in non-small cell lung cancer by regulating microRNA-7-5p","volume":"22","author":"Wu","year":"2018","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105233_bib225","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1089\/dna.2018.4277","article-title":"Association between long noncoding RNA MEG3 polymorphisms and lung cancer susceptibility in chinese northeast population","volume":"37","author":"Yang","year":"2018","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib226","article-title":"The contribution of MALAT1 gene rs3200401 and MEG3 gene rs7158663 to the risk of lung, colorectal, gastric and liver cancer","volume":"240","author":"Wang","year":"2022","journal-title":"Pathol. Res Pr."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib227","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3892\/ol.2020.11770","article-title":"LncRNA MEG3 inhibits non-small cell lung cancer via interaction with DKC1 protein","volume":"20","author":"Yang","year":"2020","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib228","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1007\/s13277-015-4151-2","article-title":"Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163","volume":"37","author":"Su","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib229","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/1471-2407-13-461","article-title":"Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression","volume":"13","author":"Lu","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105233_bib230","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5955052","article-title":"Six MicroRNA prognostic models for overall survival of lung adenocarcinoma","volume":"2022","author":"Li","year":"2022","journal-title":"Genet Res (Camb. )"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib231","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/0008-5472.CAN-18-0692","article-title":"DNA methylation controls metastasis-suppressive 14q32-encoded miRNAs","volume":"79","author":"Oshima","year":"2019","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib232","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.18632\/oncotarget.10611","article-title":"Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer","volume":"9","author":"Molina-Pinelo","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib233","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-021-01066-6","article-title":"HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA","volume":"14","author":"Jiang","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib234","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12967-023-04190-8","article-title":"HNRNPA2B1-mediated m(6)A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p\/PTEN axis","volume":"21","author":"Li","year":"2023","journal-title":"J. Transl. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib235","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11830","article-title":"Long non\u2011coding RNA MEG3 inhibits cell migration and invasion of non\u2011small cell lung cancer cells by regulating the miR\u201121\u20115p\/PTEN axis","volume":"23","author":"Lv","year":"2021","journal-title":"Mol. Med Rep."},{"issue":"47","key":"10.1016\/j.critrevonc.2026.105233_bib236","doi-asserted-by":"crossref","first-page":"18016","DOI":"10.1074\/jbc.RA118.004006","article-title":"MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells","volume":"293","author":"Terashima","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib237","article-title":"Long noncoding ribonucleic acids maternally expressed gene 3 inhibits lung cancer tumor progression through downregulation of MYC","volume":"52","author":"Yan-Hua","year":"2015","journal-title":"Indian J. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib238","first-page":"2307","article-title":"Loss of MEG3 contributes to the enhanced migration and invasion in arsenic-induced carcinogenesis through NQO1\/FSCN1 pathway","volume":"13","author":"Tu","year":"2023","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105233_bib239","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115724","article-title":"Down-regulation of lncRNA MEG3 promotes chronic low dose cadmium exposure-induced cell transformation and cancer stem cell-like property","volume":"430","author":"Lin","year":"2021","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.critrevonc.2026.105233_bib240","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.2147\/OTT.S146423","article-title":"LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p\/SOX7 axis","volume":"10","author":"Wang","year":"2017","journal-title":"Onco Targets Ther."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib241","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114586","article-title":"The long noncoding RNA MEG3 contributes to cisplatin resistance of human lung adenocarcinoma","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib242","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.3892\/mmr.2015.3897","article-title":"Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT\/beta-catenin signaling pathway","volume":"12","author":"Xia","year":"2015","journal-title":"Mol. Med Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib243","first-page":"1020","article-title":"LncRNA MEG3 promotes the sensitivity of vincristine by inhibiting autophagy in lung cancer chemotherapy","volume":"22","author":"Xia","year":"2018","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib244","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbrc.2018.08.142","article-title":"Paclitaxel promotes lung cancer cell apoptosis via MEG3-P53 pathway activation","volume":"504","author":"Xu","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105233_bib245","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.phymed.2015.05.071","article-title":"Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer","volume":"22","author":"Zamani","year":"2015","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib246","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00280-017-3238-4","article-title":"Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer","volume":"79","author":"Zhang","year":"2017","journal-title":"Cancer Chemother. Pharm."},{"issue":"8-9","key":"10.1016\/j.critrevonc.2026.105233_bib247","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.phymed.2012.03.005","article-title":"Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549\/DDP cell apoptosis through HIF-1alpha and caspase-3 mechanisms","volume":"19","author":"Ye","year":"2012","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib248","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/acs.jmedchem.5b01203","article-title":"Discovery of new monocarbonyl ligustrazine-curcumin hybrids for intervention of drug-sensitive and drug-resistant lung cancer","volume":"59","author":"Ai","year":"2016","journal-title":"J. Med Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib249","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13046-019-1234-8","article-title":"Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death","volume":"38","author":"Chen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib250","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/aps.2016.164","article-title":"Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer","volume":"38","author":"Gong","year":"2017","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.critrevonc.2026.105233_bib251","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109457","article-title":"Long non-coding RNA MEG3 regulates migration and invasion of lung cancer stem cells via miR-650\/SLC34A2 axis","volume":"120","author":"Zhao","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib252","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12957-021-02346-8","article-title":"Effects of LncRNA MEG3 on immunity and autophagy of non-small cell lung carcinoma through IDO signaling pathway","volume":"19","author":"Wang","year":"2021","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib253","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ncrna.2022.09.011","article-title":"Circular RNAs: new layer of complexity evading breast cancer heterogeneity","volume":"8","author":"Dawoud","year":"2023","journal-title":"Noncoding RNA Res"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib254","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105233_bib255","first-page":"231","article-title":"Knowledge, attitude and practice around","volume":"12","author":"Al-Mousa","year":"2020","journal-title":"Breast Cancer Mammography Screening Jordanian Women. Breast Cancer (Dove Med Press"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib256","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1186\/s12885-019-6311-z","article-title":"The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105233_bib257","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174287","article-title":"Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review","volume":"13","author":"Lukasiewicz","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib258","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12935-024-03317-1","article-title":"Pan-inhibition of the three H(2)S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer","volume":"24","author":"Dawoud","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib259","article-title":"Breast cancer: a molecularly heterogenous disease needing subtype-specific treatments","volume":"8","author":"Testa","year":"2020","journal-title":"Med Sci. (Basel)"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib260","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042070","article-title":"Hijacking 5-fluorouracil chemoresistance in triple negative breast cancer via microRNAs-loaded chitosan nanoparticles","volume":"25","author":"Fahmy","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib261","first-page":"23","article-title":"Targeting breast cancer metastasis","volume":"9","author":"Jin","year":"2015","journal-title":"Breast Cancer (Auckl)"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105233_bib262","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.7150\/ijbs.60292","article-title":"Cisplatin induces pyroptosis via activation of MEG3\/NLRP3\/caspase-1\/GSDMD pathway in triple-negative breast cancer","volume":"17","author":"Yan","year":"2021","journal-title":"Int J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib263","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10517-022-05627-8","article-title":"Hypermethylation of long non-coding RNA Genes group in the breast cancer development and progression","volume":"173","author":"Selezneva","year":"2022","journal-title":"Bull. Exp. Biol. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib264","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.ygeno.2021.04.015","article-title":"LncRNA MEG3 regulates breast cancer proliferation and apoptosis through miR-141-3p\/RBMS3 axis","volume":"113","author":"Dong","year":"2021","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib265","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12935-022-02463-8","article-title":"DNMT1 facilitates growth of breast cancer by inducing MEG3 hyper-methylation","volume":"22","author":"Zhu","year":"2022","journal-title":"Cancer Cell Int"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib266","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1002\/jcb.27982","article-title":"Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-kappaB and p53","volume":"120","author":"Zhang","year":"2019","journal-title":"J. Cell Biochem"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib267","first-page":"5941","article-title":"Functional impact of the long non-coding RNA MEG3 deletion by CRISPR\/Cas9 in the human triple negative metastatic Hs578T cancer cell line","volume":"18","author":"Deocesano-Pereira","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105233_bib268","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1824166","article-title":"The long Noncoding Rna Meg3 Retains Epithelial-Mesenchymal Transition by sponging miR-146b-5p to regulate SLFN5 expression in breast cancer cells","volume":"2022","author":"Gu","year":"2022","journal-title":"J. Immunol. Res"},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105233_bib269","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1080\/15384101.2020.1839700","article-title":"Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513\/PBLD axis in breast cancer cells","volume":"19","author":"Zhu","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.critrevonc.2026.105233_bib270","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.143955","article-title":"MYC-driven regulation of long non-coding RNA profiles in breast cancer cells","volume":"714","author":"Tokgun","year":"2019","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib271","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3291","article-title":"The lncRNA MEG3\/miR-16-5p\/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells","volume":"23","author":"Tao","year":"2021","journal-title":"J. Gene Med"},{"issue":"42","key":"10.1016\/j.critrevonc.2026.105233_bib272","doi-asserted-by":"crossref","first-page":"73282","DOI":"10.18632\/oncotarget.19931","article-title":"Potential applications of MEG3 in cancer diagnosis and prognosis","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105233_bib273","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13236102","article-title":"The Role of long non-coding RNAs (lncRNAs) in female oriented cancers","volume":"13","author":"Naz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105233_bib274","article-title":"Prognostic value of MEG3 and its correlation with immune infiltrates in gliomas","volume":"12","author":"Xu","year":"2021","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib275","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","article-title":"Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression","volume":"70","author":"Zhang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105233_bib276","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.537763","article-title":"Long non-coding RNA MEG3 modifies cell-cycle, migration, invasion, and proliferation through AKAP12 by sponging miR-29c in meningioma cells","volume":"10","author":"Ding","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib277","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109340","article-title":"LncRNA MEG3 attenuates the malignancy of retinoblastoma cells through inactivating PI3K \/Akt\/mTOR signaling pathway","volume":"226","author":"Yan","year":"2023","journal-title":"Exp. Eye Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib278","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11010-022-04515-z","article-title":"Upregulation LncRNA MEG3 expression suppresses proliferation and metastasis in melanoma via miR-208\/SOX4","volume":"478","author":"Yang","year":"2023","journal-title":"Mol. Cell Biochem"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105233_bib279","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/jcmm.17258","article-title":"Downregulation of MEG3 and upregulation of EZH2 cooperatively promote neuroblastoma progression","volume":"26","author":"Ye","year":"2022","journal-title":"J. Cell Mol. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib280","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbrc.2013.02.083","article-title":"Microarray expression profile of long noncoding RNAs in human osteosarcoma","volume":"433","author":"Li","year":"2013","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.critrevonc.2026.105233_bib281","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2022.01.026","article-title":"Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy","volume":"343","author":"Huang","year":"2022","journal-title":"J. Control Release"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib282","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4149\/neo_2015_065","article-title":"Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1","volume":"62","author":"Wang","year":"2015","journal-title":"Neoplasma"},{"key":"10.1016\/j.critrevonc.2026.105233_bib283","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.biopha.2018.06.087","article-title":"LncRNA MEG3 enhances (131)I sensitivity in thyroid carcinoma via sponging miR-182","volume":"105","author":"Liu","year":"2018","journal-title":"Biomed. Pharm."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib284","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/1386207322666181231151900","article-title":"Analysis of four types of leukemia using gene ontology term and kyoto encyclopedia of genes and genomes pathway enrichment scores","volume":"23","author":"Lu","year":"2020","journal-title":"Comb. Chem. & High. Throughput Screen."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib285","doi-asserted-by":"crossref","first-page":"12070","DOI":"10.1038\/s41598-019-48445-1","article-title":"An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States","volume":"9","author":"Hao","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105233_bib286","unstructured":"Leukemia & Lymphoma Society. Leukemia. 2023 10 August 2023]; Available from: \u3008https:\/\/www.lls.org\/facts-and-statistics\/facts-and-statistics-overview#Leukemia\u3009."},{"key":"10.1016\/j.critrevonc.2026.105233_bib287","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113392","article-title":"Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies","volume":"144","author":"Sun","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib288","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/ijlh.12081","article-title":"Acute myeloid leukemia: advances in diagnosis and classification","volume":"35","author":"Hasserjian","year":"2013","journal-title":"Int. J. Lab. Hematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib289","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ajh.25011","article-title":"Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring","volume":"93","author":"Jabbour","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib290","first-page":"a035220","article-title":"Chronic lymphocytic leukemia","author":"Chiorazzi","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib291","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.semdp.2011.02.008","article-title":"Pathobiology of acute lymphoblastic leukemia","volume":"28","author":"Paolini","year":"2011","journal-title":"Semin. Diagn. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib292","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.leukres.2009.06.019","article-title":"CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes","volume":"34","author":"Benetatos","year":"2010","journal-title":"Leuk. Res"},{"issue":"ement 1","key":"10.1016\/j.critrevonc.2026.105233_bib293","article-title":"Relationship between altered gene expression and DNA methylation of the DLK1-DIO3 region in azacitidine-treated patients with myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes","volume":"132","author":"Dostalova Merkerova","year":"2018","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105233_bib294","doi-asserted-by":"crossref","first-page":"18337","DOI":"10.18632\/oncotarget.15440","article-title":"TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population","volume":"8","author":"Yao","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib295","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1038\/s41467-021-26093-2","article-title":"TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis","volume":"12","author":"Tulstrup","year":"2021","journal-title":"Nat. Commun."},{"issue":"39","key":"10.1016\/j.critrevonc.2026.105233_bib296","doi-asserted-by":"crossref","first-page":"65211","DOI":"10.18632\/oncotarget.18059","article-title":"microRNA-22 can regulate expression of the long non-coding RNA MEG3 in acute myeloid leukemia","volume":"8","author":"Yao","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105233_bib297","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/leu.2017.116","article-title":"Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways","volume":"31","author":"Lyu","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2026.105233_bib298","doi-asserted-by":"crossref","DOI":"10.1016\/j.mgene.2019.100636","article-title":"Association between WT1 and MEG3 polymorphisms and risk of acute myeloid leukemia","volume":"23","author":"Mazraeh","year":"2020","journal-title":"Meta Gene"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib299","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13148-019-0643-z","article-title":"Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival","volume":"11","author":"Sellers","year":"2019","journal-title":"Clin. Epigenetics"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib300","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/ijlh.13225","article-title":"LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155","volume":"42","author":"Yu","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib301","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/00365513.2021.1881998","article-title":"Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients","volume":"81","author":"Gao","year":"2021","journal-title":"Scand. J. Clin. Lab. Investig."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib302","doi-asserted-by":"crossref","first-page":"27","DOI":"10.21873\/cgp.20301","article-title":"Novel contribution of long non-coding RNA <em>MEG3<\/em> genotype to prediction of childhood leukemia risk","volume":"19","author":"PEI","year":"2022","journal-title":"Cancer Genom. Proteom."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib303","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12967-022-03456-x","article-title":"Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3\/MYC axis","volume":"20","author":"Wang","year":"2022","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib304","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4062\/biomolther.2016.162","article-title":"LncRNA MEG3 regulates imatinib resistance in chronic myeloid leukemia via suppressing MicroRNA-21","volume":"25","author":"Zhou","year":"2017","journal-title":"Biomol. Ther. (Seoul. )"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib305","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4149\/neo_2015_115","article-title":"microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia","volume":"62","author":"Jurkovicova","year":"2015","journal-title":"Neoplasma"},{"key":"10.1016\/j.critrevonc.2026.105233_bib306","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biopha.2018.05.047","article-title":"Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21","volume":"104","author":"Li","year":"2018","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105233_bib307","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ebiom.2018.07.013","article-title":"The long noncoding RNA MEG3 and its target miR-147 regulate JAK\/STAT pathway in advanced chronic myeloid leukemia","volume":"34","author":"Li","year":"2018","journal-title":"eBioMedicine"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib308","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1052-5149(03)00039-X","article-title":"Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation","volume":"13","author":"Weber","year":"2003","journal-title":"Neuroimaging Clin. N. Am."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib309","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10552-019-01155-5","article-title":"Global patterns and trends in the incidence of non-Hodgkin lymphoma","volume":"30","author":"Miranda-Filho","year":"2019","journal-title":"Cancer Causes & Control"},{"key":"10.1016\/j.critrevonc.2026.105233_bib310","unstructured":"American Cancer Society. Key statistics for hodgkin lymphoma. 2023b [cited 9 August 2023; Available from: \u3008https:\/\/www.cancer.org\/cancer\/types\/hodgkin-lymphoma\/about\/key-statistics.html\u3009."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105233_bib311","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","article-title":"Aggressive lymphomas","volume":"362","author":"Lenz","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105233_bib312","doi-asserted-by":"crossref","first-page":"8144","DOI":"10.1002\/jcb.28093","article-title":"MEG3 affects the progression and chemoresistance of T-cell lymphoblastic lymphoma by suppressing epithelial-mesenchymal transition via the PI3K\/mTOR pathway","volume":"120","author":"Deng","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105233_bib313","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1080\/15257770.2022.2104870","article-title":"Association between PAX8AS1 (rs4848320C\u2009>\u2009T, rs1110839\u2009G\u2009>\u2009T, and rs6726151 T\u2009>\u2009G) and MEG3 (rs7158663) gene polymorphisms and non-Hodgkin lymphoma risk","volume":"41","author":"Mirzazadeh","year":"2022","journal-title":"Nucleosides Nucleotides & Nucleic Acids"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib314","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/ijlh.13225","article-title":"LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155","volume":"42","author":"Yu","year":"2020","journal-title":"Int J. Lab Hematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib315","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/00365513.2021.1881998","article-title":"Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients","volume":"81","author":"Gao","year":"2021","journal-title":"Scand. J. Clin. Lab Invest"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib316","doi-asserted-by":"crossref","first-page":"27","DOI":"10.21873\/cgp.20301","article-title":"Novel contribution of long non-coding RNA MEG3 genotype to prediction of childhood leukemia risk","volume":"19","author":"Pei","year":"2022","journal-title":"Cancer Genom. Proteom."},{"key":"10.1016\/j.critrevonc.2026.105233_bib317","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ebiom.2018.07.013","article-title":"The long noncoding RNA MEG3 and its target miR-147 regulate JAK\/STAT pathway in advanced chronic myeloid leukemia","volume":"34","author":"Li","year":"2018","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib318","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13046-023-02670-9","article-title":"The \u03b2-catenin-LINC00183-miR-371b-5p-Smad2\/LEF1 axis promotes adult T-cell lymphoblastic lymphoma progression and chemoresistance","volume":"42","author":"Huang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105233_bib319","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1080\/15257770.2022.2104870","article-title":"Association between PAX8AS1 (rs4848320C\u2009>\u2009T, rs1110839\u2009G\u2009>\u2009T, and rs6726151 T\u2009>\u2009G) and MEG3 (rs7158663) gene polymorphisms and non-Hodgkin lymphoma risk","volume":"41","author":"Mirzazadeh","year":"2022","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.critrevonc.2026.105233_bib320","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fcell.2022.997633","article-title":"A review of current evidence about lncRNA MEG3: a tumor suppressor in multiple cancers","volume":"10","author":"Xu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105233_bib321","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.3390\/cancers14246032","article-title":"The biological roles and molecular mechanisms of long non-coding RNA MEG3 in the hallmarks of cancer","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105233_bib322","first-page":"2022","article-title":"LncRNA MEG3: potential stock for precision treatment of cardiovascular diseases","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105233_bib323","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12253-019-00614-3","article-title":"MEG3: an oncogenic long non-coding RNA in different cancers","volume":"25","author":"Al-Rugeebah","year":"2019","journal-title":"Pathol. & Oncol. Res."},{"key":"10.1016\/j.critrevonc.2026.105233_bib324","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fonc.2025.1519103","article-title":"Deciphering the mysteries of MEG3 LncRNA and its implications in genitourinary cancers","volume":"15","author":"Assal","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib325","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4309161","article-title":"Tumor-suppressive function of lncRNA-MEG3 in glioma cells by regulating miR-6088\/SMARCB1 axis","volume":"2020","author":"Gong","year":"2020","journal-title":"Biomed. Res Int"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105233_bib326","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/FPC.0000000000000534","article-title":"MEG3 in hematologic malignancies: from the role of disease biomarker to therapeutic target","volume":"34","author":"Zhang","year":"2024","journal-title":"Pharm. Genom."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib327","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1210\/me.2014-1304","article-title":"Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors","volume":"29","author":"Modali","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105233_bib328","article-title":"Association between WT1 and MEG3 polymorphisms and risk of acute myeloid leukemia","volume":"23","author":"Mazraeh","year":"2019","journal-title":"Meta Gene"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib329","doi-asserted-by":"crossref","first-page":"8320","DOI":"10.1038\/s41598-017-08890-2","article-title":"Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105233_bib330","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15288","article-title":"Nanoconjugated long non-coding RNA MEG3 as a new therapeutic approach for Hepatocellular carcinoma","volume":"9","author":"Elzallat","year":"2023","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105233_bib331","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/pharmaceutics15020598","article-title":"Exosome-based carrier for RNA delivery: progress and challenges","volume":"15","author":"Lu","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105233_bib332","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12964-021-00796-x","article-title":"Drug delivery strategy in hepatocellular carcinoma therapy","volume":"20","author":"Yang","year":"2022","journal-title":"Cell Commun. Signal."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:17:18Z","timestamp":1776104238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826001204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":332,"alternative-id":["S1040842826001204"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105233","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternally Expressed Gene 3 (MEG3) LncRNA: The silent guardian against solid and hematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105233"}}